Smoking, Tobacco Clinical Trial
Official title:
Carbon Monoxide Breath Sensor System (COBSS) Performance, Human Factors, and Usability Assessment in a Single Visit
NCT number | NCT03148613 |
Other study ID # | CS-401 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | February 2, 2017 |
Est. completion date | August 30, 2017 |
Verified date | October 2022 |
Source | Pivot Health Technologies Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Prospective, open label, single center clinical study enrolling 70 subjects to study Performance, Human Factors, and Usability for the Carbon Monoxide Breath Sensor System (COBBS)
Status | Completed |
Enrollment | 70 |
Est. completion date | August 30, 2017 |
Est. primary completion date | March 15, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Subject who self-report smoking 2 or more cigarettes each day Inclusion Criteria: - 18-80 years of age - English speaking - Owns and uses a smartphone - Willing to sign the Informed Consent Form Exclusion Criteria: • Pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | Carrot Sense | Redwood City | California |
Lead Sponsor | Collaborator |
---|---|
David Utley, MD | UserWise |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Performance Variable - Correlation of Carbon Monoxide (CO) Measurements Between COBSS and Predicate Devices | CO concentrations in parts per million (ppm) in exhaled breath from subjects at a single visit will be assessed and reported in order to compare the CO measurements from COBSS to a control (predicate) device. The correlation will be reported as an R value.
For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes. COBSS breath sample will take approximately 1 minute. Breath sample with the control device will take approximately 1 minute. The breath samples will be collected within 5-10 minutes of each other. |
1 minute | |
Primary | Human Factors - User Performance in Use Scenarios Assessment With Observer Ratings | User performance of participants in intended use scenarios will be assessed at a single visit. Participants will be observed if they can set up the device, use the device and interpret results. Observer ratings include 'Successful' and 'Unsuccessful'. Specific attention will be given to assess if any harms can occur from observed use errors. Outcome measure data table is tally of participants who were 'Successful' in each use scenario.
For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes. Observations are made throughout the study session. Assessments for individual tasks will take approximately 1 minute and assessments will be made over the study session which can last up to 90 minutes. |
1 minute for each question; up to 90 minutes for study session | |
Secondary | User Documentation Assessment With Questionnaire With Observer Ratings | Participant understanding of user documentation will be assessed at single visit. User documentation includes packaging information, quick start guide, reference card, and user manual. Observer ratings include 'Successful' and 'Unsuccessful'.
For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes. Observations are made throughout the study session. Assessments for individual tasks will take approximately 1 minute each. The User documentation assessment portion of the study session will last up to 30 minutes. The 5-Point Likert Scale for Clarity has the following answer options: 5 - Very Clear; 4 - Clear; 3 - Neither Clear nor Unclear; 2 - Unclear; and 1 - Very Unclear. Higher values of this scale represent a better outcome, which is greater clarity/understanding. |
Up to 90 minutes | |
Secondary | Number of Participants Answering "No" for the Subjective Feedback With Questionnaire | Subjective feedback focusing on any concerns (i.e. 'yes', 'no') on using device will be assessed at single visit.
For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes. *Row title truncated due to character limit. Actual question asked: Were there any points during this portion of the study that you experienced difficulty or had concerns about the product? Subjective feedback focusing on any concerns prior to the conclusion of the study session. Subjective feedback questions will take approximately 1-3 minutes each. The Subjective feedback portion of the study session will last up to 5 to 15 minutes. |
Up to 90 minutes | |
Secondary | Participant Assessment With Questionnaire Rating Scales | Participant will be asked to provide ratings on the following:
How would you rate the ease or difficulty using the device and phone app? 5 - Very Clear; 4 - Clear; 3 - Neither Clear nor Unclear; 2 - Unclear; 1 - Very Unclear How easy or difficult was it to understand and interpret the test results? For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 90 minutes. Participant will provide the ratings prior to the conclusion of the study session. Participant assessment with questionnaire rating scales will take approximately 1-2 minutes each. The Subjective feedback portion of the study session will last up to 5 minutes. |
Up to 90 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04133064 -
Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study
|
N/A | |
Completed |
NCT06105424 -
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT03597607 -
Evaluation of an Intensive Individualized Smoking Cessation Program Delivered by Pharmacists
|
N/A | |
Completed |
NCT05960305 -
CSD201204 An Actual Use Study of P12 Electronic Nicotine Delivery System Among U.S. Adult Smokers
|
N/A | |
Terminated |
NCT03326128 -
High Dose Bupropion for Smoking Cessation - Pilot Study
|
Phase 2 | |
Completed |
NCT04808609 -
Smoking Cessation Pilot for People Living With HIV (PLWH)
|
N/A | |
Completed |
NCT04310735 -
Examining Brain Responses Linked to Emotion in Individuals Who Smoke Cigarettes
|
N/A | |
Completed |
NCT03553992 -
An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers
|
N/A | |
Enrolling by invitation |
NCT05554120 -
The Next Step in Smoking Prevention: the Reduction of Tobacco Retail Outlets, a Comprehensive Policy Evaluation
|
||
Completed |
NCT03015597 -
Pilot Study of Contingency Management for Smoking Cessation
|
N/A | |
Completed |
NCT05506046 -
Messages About Reduced Nicotine in Combusted Tobacco Products
|
N/A | |
Active, not recruiting |
NCT04982952 -
Contingency Management for Smoking Cessation
|
N/A | |
Recruiting |
NCT05992272 -
Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer
|
||
Completed |
NCT02428244 -
Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients
|
N/A | |
Recruiting |
NCT03962660 -
Harm Reduction for Tobacco Smoking With Support of Tobacco-Replacing Electronic Nicotine Delivery Systems
|
N/A | |
Completed |
NCT03200236 -
The Lung Screening, Tobacco and Health Project
|
Phase 3 | |
Completed |
NCT04791722 -
Optimizing Smoke-free Residential Housing Policies
|
N/A | |
Completed |
NCT02968381 -
A Guided Imagery Tobacco Cessation Intervention Delivered by a Quit Line and Website
|
N/A | |
Completed |
NCT06456645 -
Effects of Smoking on Placenta and Lactation
|